April 20, 2009

GLAXOSMITHKLINE: Boniva Patent Infringement Actions Ongoing

COMPANIES: GlaxoSmithKline Plc | Roche Laboratories
Subscribe

Roche Laboratories’ Boniva patent infringement actions against several generic drug manufacturers are ongoing, according to GlaxoSmithKline Plc’s Form 20-F filed with the U.S. Securities and Exchange Commission on March 4,…

TO CONTINUE READING,LOGIN or
TOPICS: Drugs/Pharmaceuticals | Legal Issues, Litigation | Patents, Intellectual Prop. | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: United Kingdom